Skip to content

Continuous Glucose Monitoring in Prediabetes

Diabetes Prevention Combining CGM and Artificial Intelligence Health Education

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06472297
Acronym
G1
Enrollment
23
Registered
2024-06-25
Start date
2024-06-01
Completion date
2024-09-30
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-diabetes

Keywords

Prediabetes, Glucose management, Feedback, Narrative education, Artificial intelligence, Contingency-shaped learning

Brief summary

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.

Detailed description

Video narratives will be provided by Latino community health workers, known as Promotores de Salud (PdS), who will wear and experience the continuous glucose monitoring (CGM) system and its glycemic variability feedback. Study 1 (G1) is a Phase 0 intervention development study, enrolling a sample of 20 Spanish- and/or English-speaking PdS who test positive for pre-diabetes via a finger prick screening. Participants will wear CGM devices for 20 days, during which they will record daily narratives about their experiences with the CGM feedback and their glucose variability. Structured interviews between staff and participants will explore the benefits and barriers of CGM use. These recorded video clips will serve as the foundation for educational cinematic smartphone videos for future interventions. Artificial intelligence (AI) tools will be used to translate the text, audio, and video clips into various languages for broad dissemination. Blood glucose levels in mg/dL will be recorded continuously over the wear period.

Interventions

DEVICEThe continuous glucose monitoring system

CGM device worn on back of the arm and glucose readings are shown on the participant's smartphone as a continuous data stream.

Sponsors

University of Southern California
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Masking description

The CGM system feedback is unmasked. The CGM is automatically recorded and does not require an outcomes assessor.

Intervention model description

A case series of participants wear an unmasked CGM sensor for a condition lasting 20 days while recording daily narratives of their experience.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Prediabetes by finger prick blood A1C% * Centers for Disease Control and Prevention (CDC) prediabetes risk test score of 5 or higher * Willingness to wear CGM sensor * Latino community health worker

Exclusion criteria

* Currently pregnant * Less than 18 years of age, which is adult in California * Diagnosed with any disorder that interferes with glucose * Influential medical disorder/event affecting ability to participate in study * Incompatible smartphone device not pairing with Dexcom G6 app

Design outcomes

Primary

MeasureTime frameDescription
Change in Mean Glucose (mg/dL) From BaselineUp to 20 days of continuous CGM wear, comprising two sequential 10-day assessment periods (baseline Phase A and subsequent Phase B).Mean glucose was derived from continuous glucose monitoring (CGM) data obtained from the Dexcom Clarity system. Raw glucose values were processed and analyzed using the R statistical software package iglu to generate the full CGM variability metrics panel. For each participant, mean glucose was calculated separately for each 10-day assessment period. The outcome measure represents the change in mean glucose, defined as the difference between the baseline (Phase A) 10-day assessment period and the subsequent (Phase B) 10-day assessment period.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid S Black, PhD MPH

University of Southern California

Participant flow

Recruitment details

Recruitment and preliminary screening activities occurred between 5/24/2024 and 8/30/2024, using baseline screening telephone calls. The Study Start Date of 6/1/2024 reflects the date on which the first participant was formally enrolled in the study. The target population included 20 community health workers who had been actively working within the past six months, were diagnosed with prediabetes, and primarily resided in Los Angeles County.

Baseline characteristics

Characteristic
Age, Continuous50.0 years
Body Mass Index31.8 kg/m²
Centers for Disease Control and Prevention (CDC) prediabetes risk score
Scored 5 or higher
19 Participants
Centers for Disease Control and Prevention (CDC) prediabetes risk score
Scored under 5
4 Participants
Current employment status
Employed
18 Participants
Current employment status
Homemaker
2 Participants
Current employment status
Retired
2 Participants
Current employment status
Student
0 Participants
Current employment status
Unemployed
1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
23 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
HbA1c (%)
HbA1c < 5.7%
11 Participants
HbA1c (%)
HbA1c ≥ 5.7%
12 Participants
Health insurance
Private
5 Participants
Health insurance
Public
17 Participants
Health insurance
Self-cash paying
1 Participants
Highest level of education
College Degree or Higher
11 Participants
Highest level of education
High School or Less
11 Participants
Highest level of education
Some College or Vocational Training
1 Participants
Physical Activity Level (International Physical Activity Questionnaire [IPAQ])
High
10 Participants
Physical Activity Level (International Physical Activity Questionnaire [IPAQ])
Low
6 Participants
Physical Activity Level (International Physical Activity Questionnaire [IPAQ])
Moderate
7 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
20 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
3 Participants
Region of Enrollment
United States
23 participants
Self-reported history of prediabetes
No
9 Participants
Self-reported history of prediabetes
Yes
14 Participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
2 Participants
Total household income
$10,000 to $29,999
7 Participants
Total household income
$150,000 or more
0 Participants
Total household income
$30,000 to $49,999
9 Participants
Total household income
$50,000 to $69,999
3 Participants
Total household income
$70,000 to $89,999
1 Participants
Total household income
$90,000 to $149,999
1 Participants
Total household income
Less than $10,000
2 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 23
other
Total, other adverse events
4 / 23
serious
Total, serious adverse events
0 / 23

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 7, 2026